Rabies virus glycoprotein — Drug Target

10 drugs 3 marketed 7 in Phase 3

All drugs that target Rabies virus glycoprotein — marketed and clinical-stage. Includes 8 drug classes acting on this target.

Drug classes

Rabies vaccine · Rabies immunoglobulin (human) · Passive immunizing agent; immunoglobulin · Vaccine + Immunoglobulin combination · Inactivated viral vaccine · Human rabies immunoglobulin (HRIG) · Immunoglobulin (passive immunization) · Monoclonal antibody immunoglobulin (rabies-specific)

Marketed (3)

Phase 3 pipeline (7)